ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36785
0.00%
Bitcoin
61,414.31
1.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) News

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNMX
DateTimeSourceHeadlineSymbolCompany
02/14/20203:25PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
02/14/20209:57AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
02/14/20205:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
02/14/20205:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
02/14/20205:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20203:30PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:49PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:49PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:48PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:47PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:45PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:44PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:43PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:42PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:42PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:41PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
02/12/20202:40PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
02/07/202011:58AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/07/202011:58AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
02/07/202011:57AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/05/20203:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
VDRM
ViaDerma (PK)
USOTC
RDAR
Raadr (PK)
USOTC
STAL
Star Alliance (PK)
USOTC
PHIL
PHI (PK)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
VPLM
Voip Pal Com (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
AXXA
Exxe (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved